NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats
Edward N. Wilson(Stanford University), A. Claudio Cuello(University of Oxford), Sonia Do Carmo(McGill University), Hélène Hall(McGill University), Lindsay A. Welikovitch(McGill University), M. Florencia Iulita(McGill University), Morgan K. Foret(McGill University), Adriana Ducatenzeiler(McGill University), Dan Jia(Guangdong Pharmaceutical University), Adam Marks(Icahn School of Medicine at Mount Sinai), S.T.M. Allard(McGill University), Lisi Flores Aguilar(University of California, Irvine), Joshua T. Emmerson(McGill University)
Cited by 50
Related Papers
Persistent neurologic symptoms and cognitive dysfunction in non‐hospitalized Covid‐19 “long haulers”
|Annals of Clinical and Translational Neurology|2021|715
Substance P and Neurokinins
|Unknown|1987|208
Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment
|JAMA Neurology|2022|133
Studies on the trigeminal antidromic vasodilatation and plasma extravasation in the rat.
|The Journal of Physiology|1984|117
Targeting Macrophages with CAR T Cells Delays Solid Tumor Progression and Enhances Antitumor Immunity
|Cancer Immunology Research|2022|96